ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 206,56
0,21%
Dow Jones
44 556,34
0,02%
DAX
22 844,50
0,21%
Brent Oil
75,73
0,32%
Bitcoin
95 530,26
-0,03%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GT Biopharma Inc (GTBP)

  7. GT Biopharma Inc (GTBP) Actualités

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GTBP
DateHeureSourceTitreSymboleSociété
07/02/202515h32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
27/01/202513h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
23/12/202423h23Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GTBPGT Biopharma Inc
14/11/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
22/10/202403h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
17/10/202417h15Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GTBPGT Biopharma Inc
17/06/202422h26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
13/06/202422h14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
24/05/202402h31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
23/05/202412h04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
06/11/202323h21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
27/10/202323h23Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
19/09/202317h56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
05/05/202323h30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202323h29Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202301h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GTBPGT Biopharma Inc
04/05/202315h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
12/04/202301h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTBPGT Biopharma Inc
30/03/202323h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GTBPGT Biopharma Inc
14/02/202318h55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GTBPGT Biopharma Inc
04/01/202312h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GTBPGT Biopharma Inc
21/10/202212h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GTBPGT Biopharma Inc
13/09/202212h20TipRanksAnalysts Offer Insights on Healthcare Companies: Dynavax (DVAX), Ascendis Pharma (ASND) and GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
17/08/202223h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GTBPGT Biopharma Inc
15/08/202215h38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GTBPGT Biopharma Inc
25/07/202222h36Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GTBPGT Biopharma Inc
19/05/202217h45TipRanksB.Riley Financial Thinks GT Biopharma’s Stock is Going to RecoverNASDAQ:GTBPGT Biopharma Inc
29/04/202223h21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GTBPGT Biopharma Inc
19/04/202223h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GTBPGT Biopharma Inc
12/04/202212h26TipRanksGT Biopharma (GTBP) Receives a Buy from H.C. WainwrightNASDAQ:GTBPGT Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:GTBP

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
PX1
CAC 40
USI
USTECH100
US Tech 100
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
EU
RNO
Renault
NYSE
JPM
JP Morgan Chase
EU
RI
Pernod Ricard
EU
CS
Axa
NASDAQ
MSFT
Microsoft
EU
VK
Vallourec
EU
ORA
Orange
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces